Supplement reference
Apigenin
A sourced reference on Apigenin identity, evidence limits and safety context.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
Identity and product form
Apigenin is a flavonoid. The cited NLM compound record identifies the compound; it is not a clinical-evidence source. An isolated supplement differs from the foods that contain related plant compounds.
What the reviewed evidence can and cannot show
No human outcome claim is made here for apigenin. The cited record cannot support sleep, anxiety, longevity or disease claims for an isolated supplement.
Safety and limits
Product purity and co-ingredients vary. This page gives no dose, combination or treatment instructions.
Published sources
- Apigenin
National Library of Medicine, PubChem. Current NLM compound record; accessed 6 September 2026.
Supports: Compound identity and structure only; it does not establish clinical effectiveness.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.